Reducing Valence States of Co Active Sites in a Single-Atom Nanozyme for Boosted Tumor Therapy

117Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The construction of biocompatible and trackable-imaging single-atom nanozymes (SAzymes) with efficient catalytic activities is particularly desirable. Here, cobalt/titanium oxide (Co/TiO2) SAzymes are presented with cobalt atomically dispersed on nanoporous hollow TiO2 using a cation-exchange strategy. Significantly, by varying the calcination conditions, the enzyme-like activity can be enhanced tenfold. It is determined that different calcination treatments result in valence state shifts of the Co active site due to changes in the amounts of defects, which affects the catalytic kinetics. Moreover, Co/TiO2 SAzymes exhibit good intrinsic biocompatibility and excellent tolerance toward the biological medium, while the hollow structure facilitates the loading of drugs and imaging agents for image-guided chemo-chemodynamic therapy via intravenous injection. This study not only provides a paradigm shift for the preparation of biocompatible SAzymes but also presents new insights for modulating the catalytic activity of SAzymes.

Cite

CITATION STYLE

APA

Wang, H., Wang, Y., Lu, L., Ma, Q., Feng, R., Xu, S., … Wang, L. (2022). Reducing Valence States of Co Active Sites in a Single-Atom Nanozyme for Boosted Tumor Therapy. Advanced Functional Materials, 32(28). https://doi.org/10.1002/adfm.202200331

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free